Download
Download by
Scanning QR Code
No matches yet
Please check network settings and try again Refresh
Loading
Futu Hot Stocks
    Latest News
    History record delete
      Quotes All >
      News All >
      Help All >

      • Download app

        Download app

      +
      Congratulations
      You've successfully got advanced quotes worth 5000 HKD
      Download APP >>
      Quotes
      Detailed Quotes
      Company Overview
      Company ProfileCompany Executives
      Financial Analysis
      Main CompositionKey IndicatorsFinancial Statement
      Multi-dimentional Analyses
      Company Valuation Capital Tracking Short Selling Data
      Futubull > Quotes > ARDS Aridis Pharmaceuticals > Financial Statement > Income statement
      ARDS Aridis Pharmaceuticals
      0.247
      -0.023-8.52%
      Post Mkt Price
      0.251
      +0.004+1.74%
      Income statement Balance sheet Cash flow
      YOY
      Do not show
      Hide blank lines
      (FY)2022/12/31(Q4)2022/12/31(Q3)2022/09/30(Q2)2022/06/30
      Total revenue
      0 0 0 784.85% 292K
      Operating revenue
      -- 0 -- 0 -- 0 784.85% 292K
      Cost of revenue
      Gross profit
      Operating expense
      -29.78% 29.99M -13.24% 7.42M -64.75% 7.41M 28.12% 8.03M
      Selling and administrative expenses
      -2.04% 7.16M -17.59% 1.63M -0.35% 1.69M -0.77% 1.68M
      -General and administrative expense
      -2.04% 7.16M -17.59% 1.63M -0.35% 1.69M -0.77% 1.68M
      Research and development costs
      -29.82% 25.92M -7.39% 7.01M -69.17% 6.12M 38.81% 6.35M
      Other operating expenses
      -101.37% -3.09M -22.90% -1.21M 22.52% -399K -- --
      Operating profit
      29.78% -29.99M 13.24% -7.42M 64.75% -7.41M -24.11% -7.74M
      Net non-operating interest income expense
      50.61% -121K 159.11% 146K -2,800.00% -27K 8K
      Total other finance cost
      -50.61% 121K -159.11% -146K 2,800.00% 27K -- -8K
      Other net income (expense)
      -133.68% -257K 8,163.64% 887K -3,578.26% -800K -133.60% -250K
      Special income (charges)
      -- 0 -- 0 -- 0 -- 0
      Other non- operating income (expenses)
      -726.83% -257K 8,163.64% 887K -3,578.26% -800K -1,236.36% -250K
      Income before tax
      28.02% -30.37M 27.50% -6.39M 60.77% -8.24M -45.34% -7.98M
      Income tax
      Net income
      28.02% -30.37M 27.50% -6.39M 60.77% -8.24M -45.34% -7.98M
      Net income continuous Operations
      28.02% -30.37M 27.50% -6.39M 60.77% -8.24M -45.34% -7.98M
      Minority interest income
      Net income attributable to the parent company
      28.02% -30.37M 27.50% -6.39M 60.77% -8.24M -45.34% -7.98M
      Preferred stock dividends
      Other preferred stock dividends
      0 0 0 0
      Net income attributable to common stockholders
      34.43% -30.37M 27.50% -6.39M 65.87% -8.24M -45.34% -7.98M
      Basic earnings per share
      57.03% -1.62 70.65% -0.27 75.77% -0.47 8.16% -0.45
      Diluted earnings per share
      57.03% -1.62 70.65% -0.27 75.77% -0.47 8.16% -0.45
      Dividend per share
      Currency Unit
      USDUSDUSDUSD
      Accounting Standards
      US-GAAPUS-GAAPUS-GAAPUS-GAAP
      Audit Opinions
      Unqualified Opinion with Explanatory Notes------

      FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

      Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

      The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%

      Company Overview More
      CEO： Dr. Vu Truong, PhD
      Market： NASDAQ
      Listing Date： 08/14/2018
      Futu Hot List
      USHKCN
      TradeSearchNews
      SymbolLatest price%Chg

      Loading...

      Watchlist
      Back to the Top